Introduction
When a data-driven healthcare technology company needed personnel support,
they contacted Shearwater Health Life Sciences. Shearwater performed oncology abstractions and data analysis to help the company determine the best cancer
treatment options on a patient-by-patient basis.
Background
A data-driven healthcare technology company approached Shearwater Health’s
Life Sciences team for support in oncology data abstraction and outcomes
supporting precision medicine. The information gathered through healthcare
records for oncology patients is used to make better-informed, data-driven
healthcare decisions for patients with breast, colorectal, or prostate cancer.
The Challenge
The company is small and needed a people infrastructure to review healthcare
records in a complex therapeutic area. The company required support with
medical experience and the ability to maintain high quality at scale. The company
turned to Shearwater Life Sciences to fulfill these needs.
The Solution
Shearwater:
– Delivered a talented data abstraction team to perform detailed analysis with well-defined quality metrics, reviews, and ongoing
performance analysis
– Provided the skills and flexibility this project required to ramp up quickly
– Delivered flexible communication and a collaborative relationship
– Brought a solution-oriented approach that always looked to solve complex problems and not merely identify them
As a result of meeting the company’s need to scale quickly and increase capacity,
Shearwater supported the unique requirements of the client.
Leveraging clinical expertise with critical thinking, the team provided analysis of
information gathered through abstraction for data-driven cancer research aiming
to find the best care and treatment for patient cases of breast, colorectal, and
prostate cancers.
All patients are sequenced by the client in terms of genetic testing. Most patients are
receiving treatment and Shearwater supported data abstraction to aid in determining
the next best treatment regimen for the patients including investigational new drugs,
new clinical trials, and new approaches to cancer treatments.
Outcomes
Shearwater supported the unique needs of three programs across multiple projects
in oncology (breast, colorectal, and prostate cancer). Reviewing ~2,500 healthcare
records monthly, our team met or exceeded the required quality metrics (90%) with
our team of registered nurses and pharmacists. Shearwater’s resources demonstrated
the high-level critical thinking these complex projects required to enable the client
to make better-informed, data-driven healthcare decisions for patients.
With Shearwater’s quality, expertise in data collection, and prior experience with
data abstraction, the company has continually added scope as their relationship
has grown.
Conclusion
Currently, the relationship between the company and Shearwater is moving into its
third year. We have established a strong partnership with open and active engagement
and communication. Sharing a multitiered relationship at the executive, management,
and operational levels, the company considers Shearwater their strategic partner now
and for future endeavors as we help them determine the best cancer treatment
options on a patient-by-patient basis.
To partner with Shearwater’s life sciences team or for more information about our services and capabilities, visit shearwaterhealth.com
The Results
Pages Reviewed
Average Quality Rating
Cases Reviewed
Strategic Partnership
